Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy

被引：0
作者：
Seow, Cynthia H. [1 ]
Casteele, Niels Vande [2 ]
Panaccione, Remo [1 ]
机构：
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷 / 11期
关键词：
ADALIMUMAB; INFLIXIMAB;
D O I：
10.1093/ecco-jcc/jjy082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1379 / 1380
页数：2
相关论文
共 50 条
[41]   The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's Disease [J].
Greener, Tomer ;
Boland, Karen ;
Steinhart, A. Hillary ;
Silverberg, Mark S. .
JOURNAL OF CROHNS & COLITIS, 2018, 12 (04) :458-464
[42]   Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients [J].
Peer, Faseeha C. ;
Miller, Andrew ;
Pavli, Paul ;
Subramaniam, Kavitha .
INTERNAL MEDICINE JOURNAL, 2017, 47 (12) :1445-1448
[43]   The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease [J].
Shale, Matthew J. .
BRITISH MEDICAL BULLETIN, 2009, 92 (01) :61-77
[44]   Salmonella enterica Arthritis in a Patient with Rheumatoid Arthritis Receiving Anti-tumour Necrosis Factor Therapy [J].
Bubonja-Sonje, M. ;
Rubinic, D. ;
Anic, F. ;
Novak, S. ;
Vuckovic, D. ;
Abram, M. .
WEST INDIAN MEDICAL JOURNAL, 2013, 62 (03) :270-272
[45]   Editorial: therapeutic de-escalation of anti-tumour necrosis factor therapy - is less enough? [J].
Papamichael, K. ;
Cheifetz, A. S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) :1265-1266
[46]   Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis [J].
Shihab, Zaid ;
Yeomans, Neville D. ;
De Cruz, Peter .
JOURNAL OF CROHNS & COLITIS, 2016, 10 (08) :979-988
[47]   Safety of Tumour Necrosis Factor-α Antagonists [J].
Dinesh Khanna ;
Maureen McMahon ;
Daniel E. Furst .
Drug Safety, 2004, 27 :307-324
[48]   Editorial: anti-tumour necrosis factor antibodies - can efficacy be regained? [J].
Bar-Yoseph, H. ;
Chowers, Y. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) :1473-1474
[49]   Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience [J].
Sprakes, Michael B. ;
Hamlin, P. John ;
Warren, Lisa ;
Greer, Dan ;
Ford, Alexander C. .
JOURNAL OF CROHNS & COLITIS, 2011, 5 (04) :324-331
[50]   Anti-tumor necrosis factor-α medications and pregnancy [J].
Cristian Simon, Petru ;
Vallano, Antonio .
MEDICINA CLINICA, 2013, 141 (06) :257-259
12345